These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29970546)

  • 21. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin.
    Haukka J; Niskanen L; Auvinen A
    Int J Cancer; 2017 Dec; 141(12):2437-2449. PubMed ID: 28840596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
    PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes.
    Insin P; Prueksaritanond N
    Asian Pac J Cancer Prev; 2018 May; 19(5):1295-1302. PubMed ID: 29802690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
    Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
    Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts.
    Al Hilli MM; Bakkum-Gamez JN; Mariani A; Cliby WA; Mc Gree ME; Weaver AL; Dowdy SC; Podratz KC
    Gynecol Oncol; 2016 Feb; 140(2):270-6. PubMed ID: 26607780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of type 2 diabetes, metformin use, and risk of breast cancer.
    Park YM; Bookwalter DB; O'Brien KM; Jackson CL; Weinberg CR; Sandler DP
    Ann Oncol; 2021 Mar; 32(3):351-359. PubMed ID: 33516778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin and the incidence of viral associated cancers in patients with type 2 diabetes.
    Hicks BM; Yin H; Sinyavskaya L; Suissa S; Azoulay L; Brassard P
    Int J Cancer; 2017 Jul; 141(1):121-128. PubMed ID: 28393359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin is associated with improved survival in endometrial cancer.
    Ko EM; Walter P; Jackson A; Clark L; Franasiak J; Bolac C; Havrilesky LJ; Secord AA; Moore DT; Gehrig PA; Bae-Jump V
    Gynecol Oncol; 2014 Feb; 132(2):438-42. PubMed ID: 24269517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin and other anti-diabetic medication use and breast cancer incidence in the Nurses' Health Studies.
    Wang T; Chai B; Chen WY; Holmes MD; Erdrich J; Hu FB; Rosner BA; Tamimi RM; Willett WC; Kang JH; Eliassen AH
    Int J Cancer; 2024 Jul; 155(2):211-225. PubMed ID: 38520039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin is associated with decreased skin cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    J Am Acad Dermatol; 2018 Apr; 78(4):694-700. PubMed ID: 29246826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes.
    Han K; Pintilie M; Lipscombe LL; Lega IC; Milosevic MF; Fyles AW
    Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):507-12. PubMed ID: 26721670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin may reduce oral cancer risk in patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Jan; 7(2):2000-8. PubMed ID: 26683519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin and the risk of endometrial cancer: a population-based cohort study.
    Ko EM; Stürmer T; Hong JL; Castillo WC; Bae-Jump V; Funk MJ
    Gynecol Oncol; 2015 Feb; 136(2):341-7. PubMed ID: 25499603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
    Tseng CH
    Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer.
    Nagle CM; Crosbie EJ; Brand A; Obermair A; Oehler MK; Quinn M; Leung Y; Spurdle AB; Webb PM;
    Gynecol Oncol; 2018 Jul; 150(1):99-105. PubMed ID: 29706522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin use and cervical cancer risk in female patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Sep; 7(37):59548-59555. PubMed ID: 27486978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trial.
    Tsilidis KK; Capothanassi D; Allen NE; Rizos EC; Lopez DS; van Veldhoven K; Sacerdote C; Ashby D; Vineis P; Tzoulaki I; Ioannidis JP
    Diabetes Care; 2014 Sep; 37(9):2522-32. PubMed ID: 24898303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Mar; 8(12):18802-18810. PubMed ID: 27861146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.